Previous Close | 22.46 |
Open | 0.00 |
Bid | 22.12 x 0 |
Ask | 22.20 x 0 |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 2,223,641 |
Market Cap | 16.301B |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | 5.66 |
EPS (TTM) | 3.92 |
Earnings Date | Feb 21, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | 1.06 (4.71%) |
Ex-Dividend Date | Dec 27, 2022 |
1y Target Est | 26.36 |
Subscribe to Yahoo Finance Plus to view Fair Value for TRPL4.SA
On June 21, 2022, the FDA announced plans for a proposed rule that would establish a maximum level of nicotine in cigarettes sold in the United States. With an established patent-pending nicotine-free offering that provides an experience and sensation similar to smoking a standard tobacco cigarette, TAAT® is preparing to capitalize on this anticipated shift in the tobacco category in the United States, which is valued at approximately USD $80 billion¹. Figure 1 In an announcement dated June 21,
Image 1 Mr. Saxon, who is now Chief Executive Officer of TAAT®, served in various positions for over 20 years with Altria and PMI including heading Altria’s Corporate Venture Fund and leading PMI’s business activities as General Manager for Norway and Denmark. He has led business units with full profit and loss (P&L) responsibility ranging from USD $100 million to USD $3 billion while consistently delivering record business results Michael Saxon, who has been appointed Chief Executive Officer of
Image 1 Mr. Saxon, who is now Chief Executive Officer of TAAT®, served in various positions for over 20 years with Altria and PMI including heading Altria’s Corporate Venture Fund and leading PMI’s business activities as General Manager for Norway and Denmark. He has led business units with full profit and loss (P&L) responsibility ranging from USD $100 million to USD $3 billion while consistently delivering record business results Michael Saxon, who has been appointed Chief Executive Officer of